标题
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 16, Issue 6, Pages 827-839
出版商
Informa Healthcare
发表日期
2016-02-26
DOI
10.1517/14712598.2016.1158809
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Rapid exacerbation of neuromyelitis optica after rituximab treatment
- (2016) Yongqiang Dai et al. JOURNAL OF CLINICAL NEUROSCIENCE
- MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Philippe Beauchemin et al. Multiple Sclerosis Journal
- MS arising during Tocilizumab therapy for rheumatoid arthritis
- (2016) Philippe Beauchemin et al. Multiple Sclerosis Journal
- A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis
- (2015) X. Xu et al. Disease Models & Mechanisms
- Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders
- (2015) Jens O. Watzlawik et al. JOURNAL OF NEUROCHEMISTRY
- A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients — A twelve month follow-up
- (2015) Tobias Derfuss et al. JOURNAL OF NEUROIMMUNOLOGY
- A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis
- (2015) Bharath Wootla et al. Journal of Neuroinflammation
- Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease
- (2015) Bharath Wootla et al. MOLECULAR NEUROBIOLOGY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
- (2014) Frank Behrens et al. ANNALS OF THE RHEUMATIC DISEASES
- Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Human T helper type 1 dichotomy: origin, phenotype and biological activities
- (2014) Francesco Annunziato et al. IMMUNOLOGY
- New antibody approaches to lymphoma therapy
- (2014) Tejas Suresh et al. Journal of Hematology & Oncology
- Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein
- (2014) François Curtin et al. mAbs
- A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients
- (2014) Tobias Derfuss et al. Multiple Sclerosis Journal
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica
- (2014) Maureen A. Mealy et al. JAMA Neurology
- Anti–IL-17A Treatment Reduces Clinical Score and VCAM-1 Expression Detected by in Vivo Magnetic Resonance Imaging in Chronic Relapsing EAE ABH Mice
- (2013) Silvy Mardiguian et al. AMERICAN JOURNAL OF PATHOLOGY
- Natural autoantibodies in the physiology and pathophysiology of the immune system
- (2013) Stratis Avrameas et al. JOURNAL OF AUTOIMMUNITY
- Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis
- (2013) P. Annunziata et al. JOURNAL OF NEUROIMMUNOLOGY
- PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation
- (2013) Jens O. Watzlawik et al. PLoS One
- Human Endogenous Retrovirus Protein Activates Innate Immunity and Promotes Experimental Allergic Encephalomyelitis in Mice
- (2013) Hervé Perron et al. PLoS One
- Effect of IL-17A blockade with secukinumab in autoimmune diseases
- (2012) Dhavalkumar D Patel et al. ANNALS OF THE RHEUMATIC DISEASES
- Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor
- (2012) Iris Navarro-Millán et al. CLINICAL THERAPEUTICS
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Discovery and mechanism of ustekinumab
- (2012) Jacqueline M. Benson et al. mAbs
- CD19 as an attractive target for antibody-based therapy
- (2012) Ohad Hammer mAbs
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivo
- (2011) Elizabeth Ward et al. BRITISH JOURNAL OF HAEMATOLOGY
- A human IgM signals axon outgrowth: coupling lipid raft to microtubules
- (2011) Xiaohua Xu et al. JOURNAL OF NEUROCHEMISTRY
- Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis
- (2011) Grant A Hill-Cawthorne et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- A Single Dose of Neuron-Binding Human Monoclonal Antibody Improves Spontaneous Activity in a Murine Model of Demyelination
- (2011) Aleksandar Denic et al. PLoS One
- Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
- (2010) Amy E. Lovett-Racke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes
- (2010) J. Watzlawik et al. GLIA
- Structural Basis for the Dual Recognition of IL-12 and IL-23 by Ustekinumab
- (2010) Jinquan Luo et al. JOURNAL OF MOLECULAR BIOLOGY
- Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis
- (2010) S. Sotgiu et al. Multiple Sclerosis Journal
- Oligoclonal bands still yield clues about multiple sclerosis
- (2010) Anne H. Cross et al. Nature Reviews Neurology
- Rituximab-Associated Infections
- (2010) Juan C. Gea-Banacloche SEMINARS IN HEMATOLOGY
- Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells
- (2009) Sha Mi et al. ANNALS OF NEUROLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Monoclonal antibodies in MS: Mechanisms of action
- (2009) B. Bielekova et al. NEUROLOGY
- Natural antibodies and cancer
- (2009) H. Peter Vollmers et al. New Biotechnology
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells
- (2008) Yohei Saito et al. IMMUNOLOGY
- CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients
- (2008) F G Joseph et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification
- (2008) Stefan Steidl et al. MOLECULAR IMMUNOLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now